Add-on imeglimin versus metformin dose escalation regarding blood glucose fluctuation in patients with type 2 diabetes treated with low-dose metformi
Not Applicable
Recruiting
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000048621
- Lead Sponsor
- Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) History of anaphylaxis of imeglimin or metformin 2) Unstable diabetic retinopathy 3) Severe hepatic dysfunction, renal dysfunction(eGFR<45 mL/min/1.73m2) 4) Pregnancy 5) Diabetic ketosis, coma and precoma 6) Serious infection, pre-or post-surgery 7) Poor adherence to dietary therapy 8) Poor insulin secretion 9) Patients who thought to be inappropriate to enter this study for some reasons by physician's judgments
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method